[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100548887":3},{"organization":4,"armGroups":7,"interventions":48,"overallOfficials":82,"centralContacts":86,"locations":93,"responsibleParty":139,"collaborators":91,"id":141,"slug":91,"hasResults":142,"nctId":143,"briefTitle":144,"officialTitle":145,"acronym":146,"eligibilityCriteria":147,"healthyVolunteers":142,"sex":148,"minAge":91,"maxAge":149,"enrollmentInfo":150,"targetDuration":91,"studyType":153,"phases":154,"briefSummary":156,"conditions":157,"keywords":91,"overallStatus":96,"whyStopped":91,"lastUpdateSubmitDate":159,"lastUpdatePostDateStruct":160,"startDateStruct":163,"completionDateStruct":165,"leadSponsor":167,"locationsCount":168},{"fullName":5,"class":6},"University Hospital, Ghent","OTHER",[8,13,18,23,28,33,38,43],{"label":9,"type":6,"description":10,"interventionNames":11},"Amoxicillin-clavulanate","Patients receiving amoxicillin-clavulanate as part of routine clinical care. Study procedure: blood sampling",[12],"Other: Amoxicillin-clavulanate",{"label":14,"type":6,"description":15,"interventionNames":16},"Piperacillin-tazobactam","Patients receiving piperacillin-tazobactam as part of routine clinical care. Study procedure: blood sampling",[17],"Other: Piperacillin-tazobactam",{"label":19,"type":6,"description":20,"interventionNames":21},"Meropenem","Patients receiving meropenem as part of routine clinical care. Study procedure: blood sampling",[22],"Other: Meropenem",{"label":24,"type":6,"description":25,"interventionNames":26},"Cefazolin","Patients receiving cefazolin as part of routine clinical care. Study procedure: blood sampling",[27],"Other: Cefazolin",{"label":29,"type":6,"description":30,"interventionNames":31},"Vancomycin","Patients receiving vancomycin as part of routine clinical care. Study procedure: blood sampling",[32],"Other: Vancomycin",{"label":34,"type":6,"description":35,"interventionNames":36},"Teicoplanin","Patients receiving teicoplanin as part of routine clinical care. Study procedure: blood sampling",[37],"Other: Teicoplanin",{"label":39,"type":6,"description":40,"interventionNames":41},"Ciprofloxacin","Patients receiving ciprofloxacin as part of routine clinical care. Study procedure: blood sampling",[42],"Other: Ciprofloxacin",{"label":44,"type":6,"description":45,"interventionNames":46},"Amikacin","Patients receiving amikacin as part of routine clinical care. Study procedure: blood sampling",[47],"Other: Amikacin",[49,54,58,62,66,70,74,78],{"type":6,"name":9,"description":50,"armGroupLabels":51,"otherNames":52},"blood sampling in patients receiving amoxicillin-clavulanate as part of routine clinical care",[9],[53],"Blood sampling",{"type":6,"name":14,"description":55,"armGroupLabels":56,"otherNames":57},"blood sampling in patients receiving piperacillin-tazobactam as part of routine clinical care.",[14],[53],{"type":6,"name":19,"description":59,"armGroupLabels":60,"otherNames":61},"blood sampling in patients receiving meropenem as part of routine clinical care.",[19],[53],{"type":6,"name":24,"description":63,"armGroupLabels":64,"otherNames":65},"blood sampling in patients receiving cefazolin as part of routine clinical care.",[24],[53],{"type":6,"name":29,"description":67,"armGroupLabels":68,"otherNames":69},"blood sampling in patients receiving vancomycin as part of routine clinical care.",[29],[53],{"type":6,"name":34,"description":71,"armGroupLabels":72,"otherNames":73},"blood sampling in patients receiving teicoplanin as part of routine clinical care.",[34],[53],{"type":6,"name":39,"description":75,"armGroupLabels":76,"otherNames":77},"blood sampling and urine sampling in patients receiving ciprofloxacin as part of routine clinical care.",[39],[53],{"type":6,"name":44,"description":79,"armGroupLabels":80,"otherNames":81},"blood sampling in patients receiving amikacin as part of routine clinical care.",[44],[53],[83],{"name":84,"affiliation":5,"role":85},"Annick de Jaeger, MD","PRINCIPAL_INVESTIGATOR",[87],{"name":88,"role":89,"phone":90,"phoneExt":91,"email":92},"Pieter De Cock, PharmD","CONTACT","+32 9 332 29 69",null,"pieter.decock@uzgent.be",[94,114,126],{"facility":95,"status":96,"city":97,"state":98,"zip":99,"country":100,"cosmosGeoPoint":101,"geoPoint":106,"contacts":107},"Queen Fabiola Children's University Hospital","RECRUITING","Brussels","Brussels Capital","1020","Belgium",{"type":102,"coordinates":103},"Point",[104,105],4.34878,50.85045,{"lat":105,"lon":104},[108,111],{"name":109,"role":89,"phone":91,"phoneExt":91,"email":110},"Biarent Dominique","dominique.biarent@huderf.be",{"name":112,"role":89,"phone":91,"phoneExt":91,"email":113},"Vens Daphne","daphnevania.vens@huderf.be",{"facility":115,"status":96,"city":116,"state":91,"zip":117,"country":100,"cosmosGeoPoint":118,"geoPoint":122,"contacts":123},"University Hospital","Ghent","9000",{"type":102,"coordinates":119},[120,121],3.71667,51.05,{"lat":121,"lon":120},[124],{"name":125,"role":89,"phone":91,"phoneExt":91,"email":92},"Pieter De Cock",{"facility":127,"status":96,"city":128,"state":91,"zip":129,"country":100,"cosmosGeoPoint":130,"geoPoint":134,"contacts":135},"Universitair hospital","Leuven","3000",{"type":102,"coordinates":131},[132,133],4.70093,50.87959,{"lat":133,"lon":132},[136],{"name":137,"role":89,"phone":91,"phoneExt":91,"email":138},"Debaveye Yves","yves.debaveye@uzleuven.be",{"type":140,"investigatorFullName":91,"investigatorTitle":91,"investigatorAffiliation":91,"oldNameTitle":91,"oldOrganization":91},"SPONSOR","100548887",false,"NCT06426836","Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO)","Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation","PADECMO","Inclusion Criteria:\n\n* patients admitted to the pediatric intensive care unit or cardiac intensive care unit\n* patient age : 1,8 kg-15 years\n* patient receiving antibiotic treatment (piperacillin-tazobactam, meropenem, amoxicillin-clavulanate, cephazolin, vancomycin, teicoplanin, ciprofloxacin, amikacin)\n* intra-arterial or intravenous access other than the drug infusion line available for blood sampling (arterial line is preferred)\n* extracorporeal membrane oxygenation circuit\n\nExclusion Criteria:\n\n* no catheter in place for blood sampling\n* absence of parental\u002Fpatient consent\n* known hypersensitivity to beta-lactam antibiotics and ciprofloxacin","ALL","15 Years",{"count":151,"type":152},300,"ESTIMATED","INTERVENTIONAL",[155],"NA","Pharmacokinetics of antibiotics in critically ill neonates, infants and children on extracorporeal membrane oxygenation (ECMO).",[158,9,14,19,24,34,29,39,44],"Pharmacokinetics","2026-01-15",{"date":161,"type":162},"2026-01-16","ACTUAL",{"date":164,"type":162},"2016-08-19",{"date":166,"type":152},"2026-07-01",{"name":5,"class":6},3]